Valeant Slumps as Longtime Backer Ackman Exits With a Loss
- Shares, bonds decline after Ackman’s Pershing sells stake
- ‘Vote of no confidence’ for Valeant: Wells Fargo analyst
Bill Ackman Sells Valeant Stake After $2.8 Billion Loss
This article is for subscribers only.
Valeant Pharmaceuticals International Inc. stock slumped to the lowest since 2009 after Bill Ackman, once its biggest champion, exited the drugmaker at a loss.
After waging a costly and outspoken public defense of the controversial company, Ackman said late Monday that he sold his entire stake and would leave the board.